Navigation Links
Transcript Pharmacy Awarded Accreditation by ACHC
Date:10/20/2010

JACKSON, Miss., Oct. 20 /PRNewswire/ -- Transcript Pharmacy has been awarded accreditation status by the Accreditation Commission for Health Care, Inc. (ACHC) for specialty pharmacy services.  

"This recognition demonstrates that the level of care and quality of services we offer bring significant benefits to the patients that we serve," said President Cliff Osbon.

ACHC, a private, not-for-profit corporation which is certified to ISO 9001:2008 standards, was developed by home care and community-based providers to help companies improve business operations and quality of patient care. Referring to the value of accreditation, ACHC President Tom Cesar indicated, "The survey process leads an organization to examine its policies and practices continually to clarify its strengths and improve its weaknesses."

Accreditation is a voluntary activity where healthcare organizations submit to peer review of their internal policies, processes and patient care delivery against national standards. By attaining accreditation, Transcript Pharmacy has demonstrated its commitment to maintain a higher level of competency and strive for excellence it its products, services and customer satisfaction.  

Last month, Transcript Pharmacy landed on the Inc. 5000 List of the fastest growing privately owned businesses in America for the third year in a row. Osbon attributes the honor to loyal support from practitioners, patients and other health care industry workers, as well as their high-touch patient model.

"We foster a culture of caring which translates into more people using their medication and better health outcomes," said Osbon.

In addition to being highlighted on the List, Transcript placed 3rd among the fastest growing specialty pharmacies and among the Top 100 healthcare companies in the nation.

"We've been able to maintain the attributes of a small business while continuing to grow and offer our patients the best care," said Osbon. "Our staff truly cares about the end result for the patient, and we strive for better outcomes."

In fact, a year-long study conducted by Virginia Commonwealth University (VCU) has shown that through personalized communication with each patient, Transcript has improved compliance. Better compliance leads to fewer doctor and hospital visits, which can significantly reduce medical costs for patients.

Founded in 2002, Transcript Pharmacy specializes in serving patients with chronic medical needs like cancer, Hepatitis C and Rheumatoid Arthritis, as well as organ transplant patients. For more information, please visit www.transcriptpharmacy.com or call (866) 420-4041.


'/>"/>
SOURCE Transcript Pharmacy
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
2. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
3. Research Teams at J. Craig Venter Institute and Ludwig Institute for Cancer Research Uncover New Chromosomal Alterations in Cancer Using Transcriptome Sequencing Approach
4. Getting More From Whole-Transcript Microarrays
5. Foundation Radiology Group Forms Strategic Partnership with Transcription Experts, Acusis
6. Webmedx and NLP International Team to Bring Natural Language Processing Software to Medical Transcription
7. CVS/pharmacy Offers Flu Vaccinations in Over 4,000 Stores
8. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
9. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
10. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
11. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 28, 2017 , ... Children and adolescents who enter the ... children in the general population. That’s because foster care is designed to protect ... While no fault of their own, youth who have experienced trauma often have ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... could substantially improve drug safety and minimize the cost of development. In this ... channel inhibition using cell lines and for cardiac toxicity using induced pluripotent stem ...
(Date:4/28/2017)... Abilene, Texas (PRWEB) , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... says, reveals which name the Creator responds to and which He does not. Yisrayl ... to believe which one is the true name, but he says with a little Scripture, ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to ... ERP expert that specializes in long-term care, Brooke Grove now has the capability ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a ... he has leant his presence to an educational purpose as the host of the ... one being cancer. In a recent episode, the series focuses on thyroid cancer. , ...
Breaking Medicine News(10 mins):